Tianda Pharmaceuticals (HKSE:00455) FCF Margin % : -10.07% (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tianda Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2023 was HK$-23.0 Mil. Tianda Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was HK$228.6 Mil. Therefore, Tianda Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was -10.07%.

As of today, Tianda Pharmaceuticals's current FCF Yield % is -22.30%.

The historical rank and industry rank for Tianda Pharmaceuticals's FCF Margin % or its related term are showing as below:

HKSE:00455' s FCF Margin % Range Over the Past 10 Years
Min: -38.81 Med: -6.74 Max: 19.33
Current: -21.81

During the past 13 years, the highest FCF Margin % of Tianda Pharmaceuticals was 19.33%. The lowest was -38.81%. And the median was -6.74%.

HKSE:00455's FCF Margin % is ranked worse than
78.21% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs HKSE:00455: -21.81

Tianda Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Tianda Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals FCF Margin % Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2.75

-24.87

-38.81

-10.72

-21.81

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-21.26	-1.61	-19.90	-30.65	-10.07

Competitive Comparison of Tianda Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianda Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's FCF Margin % falls into.

Tianda Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tianda Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-116.038	/	532.089
	=	-21.81 %

Tianda Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-23.013	/	228.605
	=	-10.07 %

Tianda Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines